SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-04
👔
BIOMARIN PHARMACEUTICAL INC
@BMRN_InsiderForm 4 Filing: Dere Willard H Acquires (Grant) shares of $BMRN
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
BIOMARIN PHARMACEUTICAL INC
Ticker: $BMRN
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-02
Shares: 7,490
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Dere Willard H, holds the title of Director at BIOMARIN PHARMACEUTICAL INC.
On 2026-06-02, the insider transacted 7,490 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Dere Willard H (Director) was granted $0 of $BMRN
Post-Transaction Position: 46,440 shares
SEC Accession No: 0001628280-26-040911 (CIK: 1311569)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.